Jim Simons Daxor Corp Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Daxor Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 28,021 shares of DXR stock, worth $318,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,021

Previous 28,121 0.36%

Holding current value

$318,318

Previous $228,000 20.18%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$7.2 - $9.79 $720 - $978	-100 Reduced 0.36%	28,021 $274,000
Q1 2025 May 14, 2025	BUY	$7.0 - $8.5 $2,100 - $2,550	300 Added 1.08%	28,121 $228,000
Q4 2024 Feb 13, 2025	BUY	$7.63 - $9.89 $99,190 - $128,570	13,000 Added 87.71%	27,821 $214,000
Q3 2024 Nov 13, 2024	SELL	$7.86 - $9.7 $2,358 - $2,910	-300 Reduced 1.98%	14,821 $128,000
Q2 2024 Aug 09, 2024	SELL	$0.0 - $9.94 $0 - $1,988	-200 Reduced 1.31%	15,121 $140,000
Q4 2023 Feb 13, 2024	SELL	$7.26 - $9.6 $3,630 - $4,800	-500 Reduced 3.16%	15,321 $147,000
Q3 2023 Nov 14, 2023	BUY	$9.03 - $10.15 $4,515 - $5,075	500 Added 3.26%	15,821 $148,000
Q2 2023 Aug 11, 2023	BUY	$9.51 - $13.03 $1,902 - $2,606	200 Added 1.32%	15,321 $147,000
Q1 2023 May 12, 2023	SELL	$8.25 - $11.23 $16,500 - $22,460	-2,000 Reduced 11.68%	15,121 $166,000
Q4 2022 Feb 13, 2023	BUY	$9.1 - $13.63 $1,820 - $2,726	200 Added 1.18%	17,121 $157,000
Q3 2022 Nov 14, 2022	SELL	$12.1 - $14.23 $50,820 - $59,766	-4,200 Reduced 19.89%	16,921 $224,000
Q2 2022 Aug 12, 2022	SELL	$10.62 - $13.21 $13,805 - $17,173	-1,300 Reduced 5.8%	21,121 $279,000
Q1 2022 May 13, 2022	BUY	$10.51 - $11.52 $6,306 - $6,912	600 Added 2.75%	22,421 $239,000
Q4 2021 Feb 11, 2022	SELL	$10.59 - $11.5 $16,944 - $18,400	-1,600 Reduced 6.83%	21,821 $246,000
Q3 2021 Nov 12, 2021	SELL	$8.77 - $12.05 $4,385 - $6,025	-500 Reduced 2.09%	23,421 $274,000
Q2 2021 Aug 13, 2021	SELL	$8.9 - $14.15 $9,790 - $15,565	-1,100 Reduced 4.4%	23,921 $254,000
Q1 2021 May 13, 2021	SELL	$11.02 - $13.86 $5,510 - $6,930	-500 Reduced 1.96%	25,021 $303,000
Q4 2020 Feb 10, 2021	SELL	$12.15 - $15.77 $48,600 - $63,080	-4,000 Reduced 13.55%	25,521 $319,000
Q3 2020 Nov 13, 2020	BUY	$14.66 - $23.78 $58,640 - $95,120	4,000 Added 15.67%	29,521 $465,000
Q2 2020 Aug 13, 2020	BUY	$12.83 - $15.83 $151,650 - $187,110	11,820 Added 86.27%	25,521 $374,000
Q1 2020 May 14, 2020	BUY	$8.6 - $14.25 $22,368 - $37,064	2,601 Added 23.43%	13,701 $185,000
Q3 2019 Nov 13, 2019	BUY	$7.81 - $9.87 $4,686 - $5,921	600 Added 5.71%	11,100 $107,000
Q2 2019 Aug 12, 2019	SELL	$7.5 - $11.61 $15,000 - $23,220	-2,000 Reduced 16.0%	10,500 $83,000
Q1 2019 May 14, 2019	BUY	$9.11 - $19.52 $4,555 - $9,760	500 Added 4.17%	12,500 $141,000
Q4 2018 Feb 13, 2019	BUY	$4.7 - $9.55 $56,400 - $114,600	12,000 New	12,000 $98,000

Others Institutions Holding DXR

# of Institutions

Shares Held

99.7K

Call Options Held

Put Options Held

View Full List

About DAXOR CORP

Ticker DXR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 4,041,670
Market Cap $45.9M
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...

More about DXR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account